EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroprotection Against a Panel of Toxicants via a Novel Analog of the Natural Product Fraxinellone

Anna E Bartman, Michael A Garcia-Mares, Sarah E Preston, Mersad Raeisi, Clarence D Peiris iD, David B C Martin iD, Hans-Joachim Lehmler iD, Jonathan A Doorn iD

Chemical Research in Toxicology · 2026

DOI: 10.1021/acs.chemrestox.5c00522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2026. Verfasst von Anna E Bartman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, 180 South Grand Avenue, Iowa City, Iowa…. Hauptthemen laut MEDLINE: Benzofurans, Neuroprotective Agents, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of Environmental Health Sciences, University of Iowa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Humans are exposed to a myriad of environmental pollutants, with recent evidence indicating several of these toxicants serve as risk factors for neurodevelopmental disorders and neurodegenerative diseases. Given this, there is a need for both interventional and protective strategies; however, of concern, the mechanistic targets of these environmental pollutants are variable or unknown in some cases. A prior report indicated that analogs of the natural product fraxinellone act as potent NRF2 activators, mitigating excessive reactive oxygen species (ROS) generation and Glu toxicity in vitro. Using one of the most effective fraxinellone analogs (i.e., analog 2) for NRF2 activation identified, we sought to determine the range of protection, in vitro, against a panel of neurotoxicants with varying mechanisms for adverse effects, including 6-hydroxydopamine (6-OHDA), organochlorine pollutants, and a fungicide. The data for analog 2 were compared to those for a structurally similar but inactive analog (i.e., analog 1). The dose-response for each toxicant with PC12 and SH-SY5Y cell lines was determined. Interestingly, the fraxinellone analog provided significant protection against all agents screened: 6-OHDA, dieldrin, benomyl, PCB52 hydroxy and sulfate metabolites, and rotenone. The extent to which the fraxinellone analog mitigated toxicity varied for each toxicant. In all cases, pretreatment with analog 2 significantly decreased total cellular ROS production, and in addition, generation of mitochondrial ROS via rotenone was mitigated. Furthermore, analog 2 provides some degree of restoration of cell viability following rotenone insult. In summary, our data indicate that an analog of the natural product fraxinellone potently inhibited ROS production and toxicity, thereby protecting cells against a panel of agents with varying mechanisms from adverse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransNeuroprotective AgentsBiological ProductsAnimalsOxidopamineReactive Oxygen SpeciesHumansDibenzofuransRatsCell SurvivalDose-Response Relationship, DrugHydrocarbons, ChlorinatedPC12 CellsStructure-Activity Relationship

Substanzen

BenzofuransOxidopamineReactive Oxygen SpeciesfraxinelloneNeuroprotective AgentsDibenzofuransBiological ProductsHydrocarbons, Chlorinated

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, 180 South Grand Avenue, Iowa City, Iowa 52242, United States.
  • Department of Chemistry, College of Liberal Arts and Sciences, University of Iowa, 230 North Madison Street, Iowa City, Iowa 52242, United States.
  • Department of Occupational and Environmental Health, College of Public Health, University of Iowa, 145 North Riverside Drive, Iowa City, Iowa 52242, United States.

ORCID-Profile: Clarence D Peiris, David B C Martin, Hans-Joachim Lehmler, Jonathan A Doorn

Förderung

  • NIGMS NIH HHS
  • National Institute of Environmental Health Sciences
  • University of Iowa
  • National Institute of General Medical Sciences
  • John L. and Carol E. Lach Endowed Chair in Drug Delivery Technology

Zitieren

APA

Bartman, A. E., Garcia-Mares, M. A., Preston, S. E., Raeisi, M., Peiris, C. D., Martin, D. B. C., Lehmler, H. J., & Doorn, J. A. (2026). Neuroprotection Against a Panel of Toxicants via a Novel Analog of the Natural Product Fraxinellone. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.5c00522

Vancouver

Bartman AE, Garcia-Mares MA, Preston SE, Raeisi M, Peiris CD, Martin DBC, et al. Neuroprotection Against a Panel of Toxicants via a Novel Analog of the Natural Product Fraxinellone. Chemical Research in Toxicology. 2026. doi:10.1021/acs.chemrestox.5c00522

BibTeX
@article{Bartman2026,
  author = {Bartman, Anna E and Garcia-Mares, Michael A and Preston, Sarah E and Raeisi, Mersad and Peiris, Clarence D and Martin, David B C and Lehmler, Hans-Joachim and Doorn, Jonathan A},
  title = {Neuroprotection Against a Panel of Toxicants via a Novel Analog of the Natural Product Fraxinellone},
  journal = {Chemical Research in Toxicology},
  year = {2026},
  doi = {10.1021/acs.chemrestox.5c00522}
}
Kostenlos starten →